-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Upgrades Maravai LifeSciences to Overweight, Announces $11 Price Target

Benzinga·11/12/2026 11:36:05
Diffusion vocale
Keybanc analyst Paul Knight upgrades Maravai LifeSciences (NASDAQ:MRVI) from Sector Weight to Overweight and announces $11 price target.